- Home
- MVST vs XBIT Comparison
MVST vs XBIT Comparison
Compare MVST & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVST | XBIT |
|---|---|---|
| Founded | 2006 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Pharmaceuticals and Biotechnology |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 848.0M | 73.2M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | MVST | XBIT |
|---|---|---|
| Price | $3.01 | $2.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 62.5K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $444,504,000.00 | N/A |
| Revenue This Year | $24.19 | N/A |
| Revenue Next Year | $17.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.82 | N/A |
| 52 Week Low | $1.09 | $2.09 |
| 52 Week High | $7.12 | $5.11 |
Technical Indicators
Market Signals| Indicator | MVST | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 36.99 | 51.08 |
| Support Level | $3.28 | $2.40 |
| Resistance Level | $3.16 | $2.55 |
| Average True Range (ATR) | 0.19 | 0.12 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 19.45 | 28.57 |
Price Performance
Historical ComparisonAbout MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.